Esophageal candidiasis pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Oral candidiasis}} {{CMG}};{{AE}}{{AY}} ==Overview== Candida is a normal commensal of the skin and mucous membranes. The balance between the virulence...")
 
m (Bot: Removing from Primary care)
 
(10 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Oral candidiasis}}
{{Esophageal candidiasis}}
{{CMG}};{{AE}}{{AY}}
{{CMG}};{{AE}}{{AY}}  
==Overview==
==Overview==
[[Candida]] is a normal [[commensal]] of the skin and mucous membranes. The balance between the [[virulence]] of the [[fungus]] and the [[Immune response|host immune defense]] is responsible avoiding [[opportunistic infection]] of candida.  
[[Candida]] is a normal [[commensal]] of the skin and mucous membranes. The balance between the [[virulence]] of the [[fungus]] and the [[Immune response|host immune defense]] is responsible avoiding [[opportunistic infection]] of candida.  
Line 10: Line 10:
==Pathophysiology==
==Pathophysiology==
===Pathogenesis===
===Pathogenesis===
Candida is a [[Commensal|normal commensal]] of skin and mucous membranes. A [[Immune system|competent immune system]] and an intact regenerating healthy skin prevent the [[virulence]] of [[Candida]].
Candida is a [[Commensal|normal commensal]] of skin and mucous membranes. A [[Immune system|competent immune system]] and an intact regenerating healthy mucosa oppose the [[virulence]] of [[Candida]].


====Candida Virulence factors====
====Candida Virulence factors====
Line 23: Line 23:


===Gross Pathology===
===Gross Pathology===
Oropharyngeal Candidiasis can be in one of 4 forms:<ref name="pmid9522103">{{cite journal |vauthors=Epstein JB, Polsky B |title=Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies |journal=Clin Ther |volume=20 |issue=1 |pages=40–57 |year=1998 |pmid=9522103 |doi= |url=}}</ref>
By upper endoscopy, candida esophagitis appears as white patches on the esophageal mucosa.


====Pseudomembranous candidiasis:====
{{#ev:youtube|PKK-V07AXv8}}
On [[Speculum|speculum examination]] typical curdy white discharge is present. Usually present in newborns or in patients with [[Immunodeficiency|deficient immunity]], administering [[corticosteroids]], etc.
 
====Atrophic candidiasis:====
Appears as [[erythema]] or [[edema]] without the characteristic [[Plaques|white plaques]]. Usually, seen in patients with [[Dentures|dental dentures]].<ref name="pmid7936588">{{cite journal |vauthors=Lynch DP |title=Oral candidiasis. History, classification, and clinical presentation |journal=Oral Surg. Oral Med. Oral Pathol. |volume=78 |issue=2 |pages=189–93 |year=1994 |pmid=7936588 |doi= |url=}}</ref>
 
====Chronic hyperplastic candidiasis (Candidal leukoplakia):====
Persistent tough, adherent, white lesions that are indistinguishable from other [[leukoplakia]] except through [[biopsy]].
Seen more in smokers, patients with [[iron deficiency anemia]] or [[Cell mediated immunity|deficient cell-mediated immunity]].<ref name="urlCHRONIC HYPERPLASTTC CANDIDIASIS—CANDIDAL LEUKOPLAKIA - CAWSON - 1968 - British Journal of Dermatology - Wiley Online Library">{{cite web |url=http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2133.1968.tb11899.x/full |title=CHRONIC HYPERPLASTTC CANDIDIASIS—CANDIDAL LEUKOPLAKIA - CAWSON - 1968 - British Journal of Dermatology - Wiley Online Library |format= |work= |accessdate=}}</ref><ref name="pmid7936588">{{cite journal |vauthors=Lynch DP |title=Oral candidiasis. History, classification, and clinical presentation |journal=Oral Surg. Oral Med. Oral Pathol. |volume=78 |issue=2 |pages=189–93 |year=1994 |pmid=7936588 |doi= |url=}}</ref>
 
====Chronic mucocutaneous  candidiasis (CMCC):====
*[[Chronic mucocutaneous candidiasis|CMCC]] is a syndrome characterized by chronic or recurrent superficial candida infection in the skin and mucous membranes in association with [[Endocrinopathy|endocrinal]] and [[autoimmune diseases]].<ref name="pmid21350122">{{cite journal |vauthors=Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova JL |title=Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity |journal=Science |volume=332 |issue=6025 |pages=65–8 |year=2011 |pmid=21350122 |pmc=3070042 |doi=10.1126/science.1200439 |url=}}</ref>
*Characterized by the inability of [[T cells]] to react to [[Antigens|candidal antigens]].
*Presents with recurrent or chronic candidal infections. Infection is usually superficial though invasive candidiasis is encountered especially in [[Immunosuppression|immunocompromised patients]].<ref name="pmid18615114">{{cite journal |vauthors=Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, Hofmann H, Ring J, Traidl-Hoffmann C |title=Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22 |journal=J. Invest. Dermatol. |volume=128 |issue=11 |pages=2640–5 |year=2008 |pmid=18615114 |doi=10.1038/jid.2008.139 |url=}}</ref>
*[[Endocrinopathy|Endocrinopathies]] as [[hypoparathyroidism]] and [[adrenal insufficiency]] may accompany chronic candidiasis.
 
<div align="center">
<gallery heights="175" widths="175">
Image:Oralcandi.JPG|Oral candidiasis on the [[tongue]] and soft [[palate]].
Image:Oral candidiasis.jpg|Oral manifestations of HIV infection and AIDS. Chronic oral candidiasis in patient with AIDS. <small>Image courtesy of Professor Peter Anderson DVM PhD and published with permission. [http://www.peir.net © PEIR, University of Alabama at Birmingham, Department of Pathology] </small>
Image:Oral candidiasis 2.jpg|Soft palate showing extensive oral candidiasis in patient with AIDS. <small>Image courtesy of Professor Peter Anderson DVM PhD and published with permission. [http://www.peir.net © PEIR, University of Alabama at Birmingham, Department of Pathology] </small>
Image: Moniliasis03.jpeg| Patient with swollen gingivae was diagnosed with oral moniliasis secondary to monocytic leukemia. <SMALL><SMALL>''[http://phil.cdc.gov/phil/home.asp From Public Health Image Library (PHIL).] ''<ref name=PHIL> {{Cite web | title = Public Health Image Library (PHIL) | url = http://phil.cdc.gov/phil/home.asp}}</ref></SMALL></SMALL>
</gallery>
</div>


===Microscopic pathology:===
===Microscopic pathology:===
Line 70: Line 47:
<br>
<br>
<br>
<br>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Fungal diseases]]
[[Category:Fungal diseases]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Emergency medicine]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Primary care]]
[[Category:Otolaryngology]]
{{WH}}
[[Category:Immunology]]
{{WS}}

Latest revision as of 21:40, 29 July 2020

Esophageal candidiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esophageal candidiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal candidiasis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal candidiasis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal candidiasis pathophysiology

CDC on Esophageal candidiasis pathophysiology

Esophageal candidiasis pathophysiology in the news

Blogs on Esophageal candidiasis pathophysiology

Directions to Hospitals Treating Esophageal candidiasis

Risk calculators and risk factors for Esophageal candidiasis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Overview

Candida is a normal commensal of the skin and mucous membranes. The balance between the virulence of the fungus and the host immune defense is responsible avoiding opportunistic infection of candida. Deficiency of cell-mediated immunity or poor general status are the main risk factors for having opportunistic candidiasis. Candidiasis is usually localized to skin and mucous membranes. In rare cases, candidiasis can spread causing candidemia and distant infection. These cases are usually associated with deficient immunity . C. albicans is the main species causing infection in humans more than any other candida species.

Pathophysiology

Pathogenesis

Candida is a normal commensal of skin and mucous membranes. A competent immune system and an intact regenerating healthy mucosa oppose the virulence of Candida.

Candida Virulence factors

The main virulence factors that mediate the infection:[1]

Any condition that compromises cell-mediated immunity, worsens the general status of the patient or provide a favorable medium for Candida to form biofilms put the patient at increased risk for having candidiasis.[2]

Candidal gene VPS4 plays an important role in mucosal candidiasis specifically. Moreover, fungi with mutations affecting this gene were found to be less virulent.[3][4]

Gross Pathology

By upper endoscopy, candida esophagitis appears as white patches on the esophageal mucosa.

{{#ev:youtube|PKK-V07AXv8}}

Microscopic pathology:

Candida albicans - By Y tambe - Y tambe's file, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=233284

`

  • Microscopic examination of the wet mount with 10% KOH or saline demonstrates hyphae, pseudohyphae, and blastospores.














References

  1. Mayer FL, Wilson D, Hube B (2013). "Candida albicans pathogenicity mechanisms". Virulence. 4 (2): 119–28. doi:10.4161/viru.22913. PMC 3654610. PMID 23302789.
  2. Pappas PG (2006). "Invasive candidiasis". Infect. Dis. Clin. North Am. 20 (3): 485–506. doi:10.1016/j.idc.2006.07.004. PMID 16984866.
  3. Rane HS, Hardison S, Botelho C, Bernardo SM, Wormley F, Lee SA (2014). "Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis". Virulence. 5 (8): 810–8. doi:10.4161/21505594.2014.956648. PMID 25483774.
  4. Lee SA, Jones J, Hardison S, Kot J, Khalique Z, Bernardo SM, Lazzell A, Monteagudo C, Lopez-Ribot J (2009). "Candida albicans VPS4 is required for secretion of aspartyl proteases and in vivo virulence". Mycopathologia. 167 (2): 55–63. doi:10.1007/s11046-008-9155-7. PMID 18814053.

Template:WH Template:WS